Stay updated on GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Sign up to get notified when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.

Latest updates to the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3% 
- Check32 days agoChange DetectedThe page update appears to be a simple version bump from v3.0.2 to v3.1.0 with no substantive content changes.SummaryDifference0.1% 
- Check47 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.SummaryDifference0.2% 
- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2% 
- Check61 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility and product names related to Human Growth Hormone and its components, while removing various location and drug information references.SummaryDifference4% 
- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1% 
Stay in the know with updates to GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Enter your email address, and we'll notify you when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.